Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
12.75
-0.08 (-0.62%)
At close: Oct 30, 2026, 4:00 PM EDT
12.50
-0.25 (-1.96%)
After-hours: Oct 30, 2026, 7:30 PM EDT

IART Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
252.26235.05246.38276.4456.66513.45
Short-Term Investments
59.6728.6927.1932.69--
Cash & Short-Term Investments
311.93263.74273.57309.1456.66513.45
Cash Growth
16.44%-3.59%-11.49%-32.31%-11.06%9.21%
Receivables
248.99278.85272.37259.33263.47243.24
Inventory
464.45492.74429.09389.61324.58317.39
Prepaid Expenses
117.6296.097767.3685.7665.82
Other Current Assets
46.9428.1329.6532.6431.0313.82
Total Current Assets
1,1901,1601,0821,0581,1611,154
Property, Plant & Equipment
577.27584.9549.77496.38459.59396.25
Long-Term Investments
6.3412.7538.330.7140.034.37
Goodwill
607.83615.161,0971,0551,0391,013
Other Intangible Assets
1,0411,1351,2081,0681,1271,146
Long-Term Deferred Tax Assets
66.7169.8534.9246.0845.9956.95
Other Long-Term Assets
19.0825.1328.2127.4817.1612.07
Total Assets
3,5083,6024,0373,7823,8903,782

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
66.4295.7382.592.33102.161.84
Accrued Expenses
151.18164.5169.74144.71147.32186.64
Short-Term Debt
-87.8----
Current Portion of Long-Term Debt
49.3639.85607.7615.1138.1363.19
Current Portion of Leases
14.5914.0214.5415.2814.6214.78
Current Income Taxes Payable
1.73.65----
Current Unearned Revenue
12.0811.4610.488.547.255.3
Other Current Liabilities
33.6738.9737.131.0111.488.28
Total Current Liabilities
329455.98922.13306.98320.91340.02
Long-Term Debt
1,7781,7301,1971,4861,4051,531
Long-Term Leases
161.09163.06166.93166.85157.4290.33
Long-Term Unearned Revenue
9.4511.559.19---
Pension & Post-Retirement Benefits
-13.8415.4419.3812.3125.27
Long-Term Deferred Tax Liabilities
4.795.6660.8335.3263.3445.79
Other Long-Term Liabilities
158.64178.36120.46179.31126.1964.85
Total Liabilities
2,4412,5592,4922,1942,0852,098

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.920.920.920.910.910.9
Additional Paid-In Capital
1,3461,3381,3231,3021,2771,265
Retained Earnings
438.16423.44939.92946.86879.12698.57
Treasury Stock
-684.09-689.21-691.41-647.26-362.86-234.45
Comprehensive Income & Other
-34.51-30.08-27.57-15.1110.27-45.16
Shareholders' Equity
1,0671,0431,5451,5881,8041,685
Total Liabilities & Equity
3,5083,6024,0373,7823,8903,782

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2,0032,0351,9861,6841,6151,700
Net Cash (Debt)
-1,691-1,771-1,713-1,374-1,159-1,186
Net Cash Growth
------
Net Cash Per Share
-21.78-23.10-22.24-17.11-13.87-13.88
Filing Date Shares Outstanding
77.877.9477.2278.2281.6483.24
Total Common Shares Outstanding
77.8177.8977.1678.1783.6584.7
Working Capital
860.94703.56159.56751.06840.59813.7
Book Value Per Share
13.7113.4020.0320.3121.5719.89
Tangible Book Value
-581.85-706.36-759.26-535.41-361.09-474.23
Tangible Book Value Per Share
-7.48-9.07-9.84-6.85-4.32-5.60
Land
-4.160.950.980.971.51
Buildings
-78.3119.7514.8614.7119.03
Machinery
-444.97405.41383.47358.14206.98
Construction In Progress
-179.61196.63137.28103.8894.85
Leasehold Improvements
-181.24179.9171.06163.34155.5
SEC Filings: 10-K · 10-Q